Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Long-term Investment Intensity

Latest as of September 2024: 23.5%

Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Long-term Investment Intensity of 23.5% as of September 2024. Long-term investments of $52.97 Million represent 23.5% of total assets of $225.60 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Artiva Biotherapeutics, Inc. Common Stoc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

23.5%
LT Investments / Total Assets

Long-term Investments

$52.97 Million
USD

Total Assets

$225.60 Million
USD

Country

USA
NASDAQ

Annual Long-term Investment Intensity for Artiva Biotherapeutics, Inc. Common Stock (None–None)

The table below presents the year-by-year Long-term Investment Intensity for Artiva Biotherapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read ARTV liabilities breakdown for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points